Digital How biotech can leverage scientific enterprise SaaS By considering how to build a solid data foundation from the beginnings, smaller start-ups or biotechs can make sure they are ready to go.
Market Access Sponsored Due diligence: Identifying start-up risks & gaps hVIVO's Consulting team discusses due diligence, a structured assessment process to evaluate an asset's risk, opportunities, and value drivers.
Market Access Why 70% of pharma partnership spend misses patients Finding a start-up or building an app is the cheap part; combining capabilities into something that scales across markets is the expensive part.
Digital The real test for healthtech companies isn’t innovation – it... The Basel Area is increasingly becoming a convergence point where life sciences, advanced computing, and health technology intersect.
R&D Strategies for creating an ecosystem to support early-stage ... Learn how to foster growth for early-stage biotech companies through innovative ecosystem strategies and valuable CDMO collaborations
Digital Garbage in, garbage out: The hidden data crisis in pharma This hidden data crisis is the fundamental barrier to scaling AI in the life sciences sector.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.